Good news: mild cases of Covid-19 give long-lasting antibodies, possibly for life
New research provides high hopes for those mildly ill with Covid-19. The antibodies produced by the body are long-lasting, possibly perpetual.
New research provides high hopes for those mildly ill with Covid-19. The antibodies produced by the body are long-lasting, possibly perpetual.
100% effectiveness and a booster every 3 years: the second Russian vaccine, EpiVacCorona, could mark a step forward in the fight against Covid-19
Alberto Robiati and Gianluca Riccio guide readers through scenarios of the future: the opportunities, risks and possibilities we have to create a possible tomorrow.
News about the world of tomorrow.
We give news about the future of technology, science and society: if there is one thing that is about to arrive, it has already arrived here.
Category
Language editions
fffdddddd
© 2024 Near future - This work is distributed under license Creative Commons Attribution 4.0 International.